Key Takeaways: DEA Telemedicine Special Registration Update The Drug Enforcement Administration (DEA) has moved its long-awaited telemedicine special registration rule into final White House review, bringing clinicians and telehealth organizations closer to learning what permanent federal rules could govern prescribing controlled substances to patients who have not first been examined in person. The Office of […]
Key Takeaways: DEA Telemedicine Special Registration Update The Drug Enforcement Administration (DEA) has moved its long-awaited telemedicine special registration rule into final White House review, bringing clinicians and telehealth organizations closer to learning what permanent federal rules could govern prescribing controlled substances to patients who have not first been examined in person. The Office of […]
